Cargando…
Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) cells do not contain various receptors for targeted treatment, a reason behind the poor prognosis of this disease. In this study, biocompatible theranostic erythrocyte-derived nanoparticles (EDNs) were developed and evaluated for effective early diagnosis and tre...
Autores principales: | Choi, Moon Jung, Lee, Yeon Kyung, Choi, Kang Chan, Lee, Do Hyun, Jeong, Hwa Yeon, Kang, Seong Jae, Kim, Min Woo, You, Young Myoung, Im, Chan Su, Lee, Tae Sup, Park, Yong Serk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966336/ https://www.ncbi.nlm.nih.gov/pubmed/36839675 http://dx.doi.org/10.3390/pharmaceutics15020350 |
Ejemplares similares
-
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019) -
EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms
por: Choi, Moon Jung, et al.
Publicado: (2022) -
Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
por: Kim, Min Woo, et al.
Publicado: (2017) -
Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023) -
Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype
por: Choi, Yangsean, et al.
Publicado: (2017)